UAE’s KBW Ventures Part of $6.2M Funding for Singaporean BioTech Firm Making Milk with Animal Cells
The investment marks the second this year for KBW in Singapore’s TurtleTree Labs, which is the first in the world to use cell cultivation to produce milk.
Following its participation in a seed round funding earlier this year, UAE's KBW Ventures has announced that it has taken part in a new investment in Singaporean biotech firm, TurtleTree Labs.
Totalling at $6.2 million, the Pre-Series A round will see KBW founder, Prince Khaled bin Alwaleed bin Talal Al Saud, join TurtleTree Labs as an advisor, with a view to helping shape new market growth plans and provide other consultancy services to the company as an expert in the food tech and alternative protein sheres.
This new set-up will almost certainly impact said spheres in the UAE, as the country continues to focus on alternative means to tackle perceived, oncoming food security issues.
With the new investment, TurtleTree Labs - which was in 2019 by Fengru Lin and Max Rye and has headquarters in San Francisco and Singapore - aims to accelerate research in, and production of, bioactive proteins and complex sugars found in human milk.
